Literature DB >> 15188056

Characterization of MR-1, a novel myofibrillogenesis regulator in human muscle.

Tian-Bo Li1, Xiu-Hua Liu, Shuang Feng, Yang Hu, Wei-Xi Yang, Yue Han, Yi-Guang Wang, Li-Min Gong.   

Abstract

The actin-myosin contractile apparatus consists of several thick filament and thin filament proteins. Specific regulatory mechanisms are involved in this highly ordered process. In this paper, we reported the identification and characterization of a novel myofibrillogenesis regulator, MR-1. The MR-1 gene was cloned from human skeletal muscle cDNA library by using a strategy that involves EST data base searching, PCR and RACE. The MR-1 gene is located on human chromosome 2q35 and encodes a 142 aa protein. Northern blot revealed that the mRNA level of MR-1 was highest in the skeletal muscle and certain level of MR-1 expression was also observed in heart, liver and kidney. Immunohistochemical assay confirmed that the MR-1 protein existed in human myocardial myofibrils. It was found by yeast two-hybrid screening and confirmed by in vitro binding assay that MR-1 could interact with sarcomeric proteins, such as myosin regulatory light chain, myomesin 1 and beta-enolase. These studies suggested that MR-1 might play a regulatory role in the muscle cell and it was worth investigating further.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188056     DOI: 10.1093/abbs/36.6.412

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  13 in total

1.  Clinicopathological and prognostic significance of myofibrillogenesis regulator-1 protein expression in pancreatic ductal adenocarcinoma.

Authors:  Chang-Yong Zhao; Zi-Jian Guo; Sai-Min Dai; Yong Zhang; Jun-Jing Zhou
Journal:  Tumour Biol       Date:  2013-05-22

2.  Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.

Authors:  Jing Guo; Bin Dong; Jia-Fu Ji; Ai-Wen Wu
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

3.  High expression of myofibrillogenesis regulator-1 predicts poor prognosis for patients with hepatocellular carcinoma after curative hepatectomy.

Authors:  Chunwei Wang; Hua Xiang; Huiyuan Si; Dandan Guo; Mei Sun
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

4.  MR-1 blocks the megakaryocytic differentiation and transition of CML from chronic phase to blast crisis through MEK dephosphorylation.

Authors:  W Zhao; H He; K Ren; B Li; H Zhang; Y Lin; R-G Shao
Journal:  Blood Cancer J       Date:  2013-03-29       Impact factor: 11.037

5.  Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer.

Authors:  Renquan Lu; Min Sun; Jingjing Feng; Xiang Gao; Lin Guo
Journal:  BMC Cancer       Date:  2011-06-25       Impact factor: 4.430

6.  Myofibrillogenesis regulator 1 induces hypertrophy by promoting sarcomere organization in neonatal rat cardiomyocytes.

Authors:  Xiaoreng Wang; Xiuhua Liu; Song Wang; Kang Luan
Journal:  Hypertens Res       Date:  2012-03-15       Impact factor: 3.872

7.  Microarray-based analysis of fish egg quality after natural or controlled ovulation.

Authors:  Emilie Bonnet; Alexis Fostier; Julien Bobe
Journal:  BMC Genomics       Date:  2007-02-21       Impact factor: 3.969

8.  Crystal structure of human persulfide dioxygenase: structural basis of ethylmalonic encephalopathy.

Authors:  Ilaria Pettinati; Jürgen Brem; Michael A McDonough; Christopher J Schofield
Journal:  Hum Mol Genet       Date:  2015-01-16       Impact factor: 6.150

Review 9.  The sarcomeric M-region: a molecular command center for diverse cellular processes.

Authors:  Li-Yen R Hu; Maegen A Ackermann; Aikaterini Kontrogianni-Konstantopoulos
Journal:  Biomed Res Int       Date:  2015-04-15       Impact factor: 3.411

Review 10.  The Chemical Biology of Human Metallo-β-Lactamase Fold Proteins.

Authors:  Ilaria Pettinati; Jürgen Brem; Sook Y Lee; Peter J McHugh; Christopher J Schofield
Journal:  Trends Biochem Sci       Date:  2016-01-21       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.